Organization
BeBetter Med
6 clinical trials
Clinical trial
A Multicenter, Open Phase Ib Study of the Safety and Efficacy of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaStatus: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Orally Administered BEBT-503 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses (SAD) and Multiple Ascending Doses (MAD) in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-05-29
Clinical trial
A Multicenter, Open, Phase I Clinical Study of BEBT-908 for Injection in the Treatment of Relapsed Refractory Malignant Lymphoma, Multiple Myeloma and Chronic Lymphoblastic LeukemiaStatus: Completed, Estimated PCD: 2019-03-08
Clinical trial
An Open, Multicenter Phase II Study of the Efficacy and Safety of BEBT-908 in the Treatment of Relapsed or Refractory Diffuse Large B-cell LymphomaStatus: Active (not recruiting), Estimated PCD: 2023-12-20
Clinical trial
A Phase I, Open, Multicenter Study of BEBT-209 in Women With Advanced Breast CancerStatus: Active (not recruiting), Estimated PCD: 2023-10-20
Clinical trial
A Two-phase, Multicenter, Open Phase I Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C MutationStatus: Recruiting, Estimated PCD: 2025-05-01